Apellis Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell APLS and other ETFs, options, and stocks.

About APLS

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE.

CEO

Cedric Francois

CEOCedric Francois

Employees

710

Employees710

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

2009

Founded2009

Employees

710

Employees710

APLS Key Statistics

Market cap

2.06B

Market cap2.06B

Price-Earnings ratio

-9.12

Price-Earnings ratio-9.12

Dividend yield

—

Dividend yield—

Average volume

3.36M

Average volume3.36M

High today

$16.74

High today$16.74

Low today

$16.10

Low today$16.10

Open price

$16.69

Open price$16.69

Volume

2.42M

Volume2.42M

52 Week high

$43.99

52 Week high$43.99

52 Week low

$16.10

52 Week low$16.10

APLS News

Simply Wall St 7d

Analysts Just Slashed Their Apellis Pharmaceuticals, Inc. EPS Numbers

Market forces rained on the parade of Apellis Pharmaceuticals, Inc. ( ) shareholders today, when the analysts downgraded their forecasts for this year. Both rev...

Analyst ratings

63%

of 24 ratings

Buy

62.5%

Hold

37.5%

Sell

People also own

Based on the portfolios of people who own APLS. This list is generated using Robinhood data, and it’s not a recommendation.